{
  "query": "company incorporation status",
  "timestamp": "2025-09-06 08:24:17",
  "config": {
    "top_k": 5,
    "similarity_threshold": 0.0,
    "reranking_enabled": true,
    "hybrid_search_enabled": true,
    "hybrid_search_weight": 0.7
  },
  "results": [
    {
      "id": 1,
      "text": "Pursuant to section 12, 2, 3 of the Royal \nDecree of November 14, 2007 regarding the \nobligations of issuers of financial instruments \nadmitted to trading on a regulated market, Mr. Olivier Legrain, Chief Executive Officer (CEO), Director and Managing Director of IBA SA, and \nMrs. Soumya Chandramouli, Chief Financial \nOfficer (CFO) of IBA SA, state that, to their \nknowledge: the financial statements to which this \nannual report relates, prepared in \naccordance with applicable accounting \nstandards, give a true and fair view of \nthe assets and liabilities, financial \nposition, and results of IB",
      "similarity_score": 0.05587792204319422,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 181,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 2,
      "text": "ets \n5.7. 35 184 \n33 743 \nNon-current assets \n123 423 \n145 483 \nInventories \n5.6. 101 017 \n130 545 \nContract assets \n4.3.1. 39 391 \n38 444 \nTrade receivables \n5.7.1. 111 649 \n107 576 \nOther current assets and receivables \n5.7. 89 893 \n65 435 \nCurrent derivative financial assets \n7.3. 160 \n739 \nCash and cash equivalents \n5.8. 158 366 \n109 306 \nCurrent assets \n500 476 \n452 045 \nTOTAL ASSETS \n623 899 \n597 528 \nEQUITY AND LIABILITIES \nShare capital and Share premium \n85 980 \n85 980 \nReserves and Retained earnings \n5.9. 29 971 \n20 232 \nEQUITY \n115 951 \n106 212 \nNon-current borrowings \n5.10. 10 647",
      "similarity_score": 0.06050421677883254,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 581,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 3,
      "text": "require \na \nbalance, within the Board of Directors, among \nindependent directors, internal directors, and \ndirectors representing the shareholders. The Board of Directors must always be made up \nof (a) at least one-third of independent directors \nand (b) at least one third appointed upon \nproposal by the managing directors (hereafter \nreferred to as internal directors). The other Directors are appointed freely by the \nshareholders meeting, it being understood \nhowever that, among those directors, there \ncannot be more than two members who are, directly or indirectly, related to one and the s",
      "similarity_score": 0.06077054006804445,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 294,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 4,
      "text": "n turn \ninfluence the volume of orders that IBA obtains. These subsidies from reimbursement institutions \ndiffer greatly from one country to another. Operational risks \nSale risk \nIn general, IBAs customers are diversified \n(public and private sector) and located on \nseveral continents. Each year the Company \ndepends on multiple orders, particularly for its \nproton therapy systems that are implemented \nover several financial years. One additional \norder or one order less, or changes in an order \nthat were not anticipated at the beginning of the \nyear, are characteristics of this field of business \nthat can have a significant impact over several \naccounting periods.",
      "similarity_score": 0.0537945894858461,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 228,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 5,
      "text": "inly related to the change of \nworking capital for EUR -16.9 million and the \nnet loss of EUR -9.1 million; Negative financing cash-flow of EUR -14.4 \nmillion \nrelated \nto \nthe \nrepayment \nof \nborrowings and lease liabilities for EUR -7.5 \nmillion (mainly lease liabilities), the dividend \npaid for EUR -6.1 million and; Negative investing cash-flow of EUR -13.3 \nmillion mainly related to acquisitions of \ntangible and intangible assets of EUR -12.3 \nmillion and the convertible loan issued to \nPanTera for EUR -1.0 million. Net financial cash decreased by EUR -49.8 \nmillion from EUR 117.5 million at the end of 2022 \nto EUR 67.7 million at the end of 2023.",
      "similarity_score": 0.051441207907246135,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 522,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    }
  ]
}